Cargando...

Hyperglycemia induced by pasireotide in patients with Cushing’s disease or acromegaly

PURPOSE: Cushing’s disease (CD) and acromegaly are characterized by excessive hormone secretion resulting in comorbidities such as impaired glucose metabolism, diabetes and hypertension. Pasireotide is a new-generation, multireceptor-targeted somatostatin receptor ligand approved for CD (subcutaneou...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pituitary
Autor Principal: Silverstein, Julie M.
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2016
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4996868/
https://ncbi.nlm.nih.gov/pubmed/27405306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11102-016-0734-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!